Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays

[摘要]

[发布日期] 2010-11-25 [发布机构]

[效力级别] [学科分类]

[关键词] Infliximab;Etanercept;Adalimumab;Annexin Versus;Peripheral Blood Lymphocyte [时效性]

浏览次数：3